Skip to content
Wednesday 2 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,789.28
-0.32%
DAX
25,970.11
-1.10%
CAC 40
8,301.85
0.00%
STOXX 50
6,368.98
-0.80%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Wednesday 09 December 2020 4:50 pm

Canada becomes second country to approve Pfizer Covid-19 vaccine

By: Hannah Godfrey

Add as a preferred source on Google

Canada has become the second country in the world, following the UK, to approve the Pfizer/BioNTech Covid-19 vaccine, paving the way for distribution of shots to be delivered and administered across the country.

Canada will start receiving its first doses of Pfizer’s vaccine before the end of December, Prime Minister Justin Trudeau said on Monday.

In a statement, Canada’s health regulator Health Canada said: “Thanks to advances in science and technology, and an unprecedented level of global cooperation, today, Canada reached a critical milestone in its fight against COVID-19 with the authorization of the first COVID-19 vaccine.

“Health Canada received Pfizer’s submission on October 9, 2020 and after a thorough, independent review of the evidence, Health Canada has determined that the Pfizer-BioNTech vaccine meets the department’s stringent safety, efficacy and quality requirements for use in Canada.”

The UK was the first country in the world to approve the Pfizer/BioNTech vaccine, which in a large clinical trial was 95% effective at preventing illness.

Canada has a firm order for 20 million doses of the vaccine, enough to inoculate 10 million people, with options to buy up to 56 million more.

The UK, meanwhile, has ordered 40 million doses of the vaccine – enough for 20 million people, with two shots each.

People in the UK started being vaccinated yesterday, with Margaret Keenan, a 90-year-old grandmother, becoming the first person in the world to receive the Pfizer COVID-19 vaccine outside of a trial in Britain.

Read more

ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus
  • International

Trending Articles

  • Vodafone and Deliveroo look to patch up Reform ties after Yusuf prison threats

  • Jaguar reveals the Type 01’s screen-free interior

  • Trio of firms poised to quit London Stock Exchange as exodus gathers pace

  • Easyjet’s over-60s recruitment push is economically necessary

  • As it happened: FTSE 100 slides as bound rout deepens; Oil jumps as Trump vows more strikes on Iran

More from Morning Wire

  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • UK debt ‘hits £3 trillion’ milestone

    Economics
    Houses of Parliament in Westminster showcasing historic architecture under a clear sky, central to UK government and politics
  • Heathrow overtaken by Istanbul as Europe’s busiest airport

    Transport & Infrastructure
    Commercial airplane landing at Heathrow Airport, seen from behind, with a prominent Heathrow sign below.
  • Amanda Blanc has worked her magic at Aviva

    Insurance
    Aviva's deal to buy Direct Line was agreed in March
  • Alfasigma to Acquire Nordic Group B.V. Expanding Its Specialty Care Portfolio and Presence in Europe

    Business Wire
  • Northern Trust Expands Relationship with First Sentier Group to Support Irish Fund Structure

    Business Wire
  • rhode Announces Official Launch Date for Its Retail Expansion in Europe with Sephora

    Business Wire
  • Options Announces CIX Trading, Canada’s Newest Alternative Trading System (ATS)

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook